Sun Pharmaceutical
SUNPHARMA.NS
$13.71
Share price
1.25%
Change (1 day)
20.16%
Change (1 year)
Categories
Revenue for Sun Pharmaceutical (SUNPHARMA.NS)
Revenue in 2023 (TTM): $5.41 B
According to Sun Pharmaceutical 's latest financial reports the company's current revenue (TTM) is $5.41 B. In 2022 the company made a revenue of $5.25 B an increase over the years 2021 revenue that were of $5.05 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sun Pharmaceutical from 2012 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $5.41 B | 2.96% |
| 2022 | $5.25 B | 3.97% |
| 2021 | $5.05 B | 14.76% |
| 2020 | $4.40 B | -1.42% |
| 2019 | $4.46 B | 8.61% |
| 2018 | $4.11 B | 1.61% |
| 2017 | $4.04 B | -11.95% |
| 2016 | $4.59 B | 12.36% |
| 2015 | $4.09 B | 47.36% |
| 2014 | $2.77 B | 10.54% |
| 2013 | $2.51 B | 28.18% |
| 2012 | $1.95 B |